Overview: Objective Parkinson’s Assessment with Kinesia HomeView™
Kinesia HomeView™ provides physicians with the resources to capture objective Parkinson’s disease symptoms from patients’ homes. Capturing symptoms at home where they matter most to a patient helps physicians prescribe more effective treatments and helps researchers understand new treatment responses. With the HomeView system, physicians have the tools to quantify tremor, assess dyskinesia and measure bradykinesia. A small take home kit, programmed to a specific patient’s symptoms and treatments, is sent home with the patient to complete different motor tests several times a day. The patient can also enter touch screen diary information about how they are feeling and when medications were taken. Physicians can view web-based reports including automated severity scoring and videos that show symptom changes during the day in response to treatments such as medication or deep brain stimulation.
Kinesia technology is an FDA cleared to market and CE marked system to quantify motor assessments in the clinic and at home
- ISO 13485: 2003 Certification: Issued 07 November 2011
- CE Marked Certification: Issued 20 December 2011
- TGA Registered: Issued 23 November 2012
- CMDCAS Health Canada: Issued 21 September 2012
- FDA Cleared: Issued 5 April 2007